Santen Pharmaceutical Co., Ltd. (SNPHF)
OTCMKTS · Delayed Price · Currency is USD
9.51
-0.60 (-5.91%)
At close: Nov 25, 2025
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of $3.6 billion as of February 12, 2026. Its market cap has increased by 6.91% in one year.
Market Cap
3.60B
Enterprise Value
3.20B
Revenue
1.84B
Ranking
n/a
PE Ratio
18.47
Stock Price
$9.51
Market Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 1.19B to 3.60B, an increase of 202.98%. That is a compound annual growth rate of 3.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.60B | 14.75% |
| Dec 30, 2025 | 3.14B | -10.67% |
| Dec 30, 2024 | 3.52B | -3.14% |
| Dec 29, 2023 | 3.63B | 15.53% |
| Dec 30, 2022 | 3.14B | -35.73% |
| Dec 30, 2021 | 4.89B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 775.26M |
| Glass House Brands | 761.25M |
| Elite Pharmaceuticals | 485.68M |
| Northwest Biotherapeutics | 413.38M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| OpGen | 337.95M |
| CytoDyn | 304.50M |